18-59431120-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_133459.4(CCBE1):​c.*4788T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0372 in 152,318 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.037 ( 187 hom., cov: 33)
Failed GnomAD Quality Control

Consequence

CCBE1
NM_133459.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.0620

Publications

0 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 18-59431120-A-G is Benign according to our data. Variant chr18-59431120-A-G is described in ClinVar as Benign. ClinVar VariationId is 327589.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0372 (5669/152318) while in subpopulation NFE AF = 0.0472 (3213/68026). AF 95% confidence interval is 0.0459. There are 187 homozygotes in GnomAd4. There are 2966 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 187 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133459.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
NM_133459.4
MANE Select
c.*4788T>C
3_prime_UTR
Exon 11 of 11NP_597716.1Q6UXH8-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
ENST00000439986.9
TSL:1 MANE Select
c.*4788T>C
3_prime_UTR
Exon 11 of 11ENSP00000404464.2Q6UXH8-1
CCBE1
ENST00000649564.1
c.*4788T>C
3_prime_UTR
Exon 12 of 12ENSP00000497183.1Q6UXH8-1
CCBE1
ENST00000650467.2
c.*4788T>C
3_prime_UTR
Exon 9 of 9ENSP00000496897.2A0A3B3IRL6

Frequencies

GnomAD3 genomes
AF:
0.0372
AC:
5668
AN:
152200
Hom.:
187
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00743
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.0321
Gnomad ASJ
AF:
0.0597
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0180
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0472
Gnomad OTH
AF:
0.0483
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.0372
AC:
5669
AN:
152318
Hom.:
187
Cov.:
33
AF XY:
0.0398
AC XY:
2966
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00743
AC:
309
AN:
41578
American (AMR)
AF:
0.0320
AC:
490
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0597
AC:
207
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0182
AC:
88
AN:
4830
European-Finnish (FIN)
AF:
0.115
AC:
1224
AN:
10610
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0472
AC:
3213
AN:
68026
Other (OTH)
AF:
0.0478
AC:
101
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
277
554
832
1109
1386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0255
Hom.:
25
Bravo
AF:
0.0314
Asia WGS
AF:
0.00895
AC:
31
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hennekam lymphangiectasia-lymphedema syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
6.9
DANN
Benign
0.68
PhyloP100
0.062
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77728352; hg19: chr18-57098352; API